...
首页> 外文期刊>British Journal of Cancer >Production of tumour necrosis factor-α by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)
【24h】

Production of tumour necrosis factor-α by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)

机译:培养的人外周血白细胞产生的肿瘤坏死因子-α响应抗肿瘤药5,6-二甲基黄嘌呤-4-乙酸(NSC 640488)

获取原文
           

摘要

The investigative anti-tumour agent 5,6-dimethylxanthenonone-4-acetic acid (DMXAA, NSC 640488), developed in this laboratory as an improved analogue of flavone acetic acid (FAA, NSC 347512), is currently in clinical trial. The ability of DMXAA to up-regulate tumour necrosis factor (TNF) mRNA and protein synthesis in cultured human peripheral blood leucocytes (HPBLs) has been investigated and compared with that of flavone acetic acid (FAA) and of bacterial lipopolysaccharide (LPS). Human peripheral blood leucocytes were isolated from buffy coats obtained from a blood transfusion centre and also from blood samples from laboratory volunteers. At a concentration of 400 microg ml(-1) and an incubation time of 2 h, DMXAA up-regulated mRNA synthesis in six of eight individuals tested, as measured by Northern blotting. The degree of up-regulation varied in different individuals from one to nine times that of control levels. In contrast, FAA caused no induction above that of control levels and in some cases suppressed expression relative to controls, extending previous data that DMXAA but not FAA up-regulates TNF mRNA in the human HL-60 tumour cell line. At the same concentration but with longer incubation times (6-12 h), DMXAA induced increases in TNF protein in 11 of 15 samples of HPBLs from buffy coats and also in 11 of 15 samples of HPBLs from volunteers, as measured by cytotoxicity assays with L929 cells. FAA caused no increase in TNF protein, while LPS induced TNF to approximately 20-fold higher levels than did DMXAA. Considerable heterogeneity of response was observed with both sources of HPBLs, and there was little or no correlation between the extent of TNF induction by DMXAA and LPS in individual samples. In vitro analysis of the response of human peripheral blood leucocytes to DMXAA may be a useful test in clinical trials of agents such as DMXAA.
机译:目前正在临床试验中,研究性的抗肿瘤药5,6-二甲基黄酮酮-4-乙酸(DMXAA,NSC 640488)是一种改进的黄酮乙酸类似物(FAA,NSC 347512)。已经研究了DMXAA在培养的人外周血白细胞(HPBLs)中上调肿瘤坏死因子(TNF)mRNA和蛋白质合成的能力,并将其与黄酮乙酸(FAA)和细菌脂多糖(LPS)进行了比较。从从输血中心获得的血沉棕黄层以及实验室志愿者的血样中分离出人外周血白细胞。浓度为400微克ml(-1),孵育时间为2小时,通过Northern印迹法测得,DMXAA上调了八个人中六个人的mRNA合成。不同个体的上调程度是对照水平的一倍至九倍。相反,FAA没有引起高于对照水平的诱导,并且在某些情况下相对于对照抑制了表达,从而扩展了先前的数据,即DMXAA而不是FAA上调人HL-60肿瘤细胞系中的TNF mRNA。在相同浓度下,但孵育时间较长(6-12小时),DMXAA诱导了来自血沉棕黄层的15个HPBLs样品中的11个以及来自志愿者的15个HPBLs样品中的11个中TNF蛋白的增加, L929细胞。 FAA不会导致TNF蛋白增加,而LPS诱导的TNF水平要比DMXAA高约20倍。两种来源的HPBLs均观察到相当大的反应异质性,个别样品中DMXAA和LPS诱导的TNF程度几乎没有相关。人外周血白细胞对DMXAA的反应的体外分析可能是对DMXAA等药物进行临床试验的有用测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号